EFFECTS OF LATE ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON LEFT-VENTRICULAR REMODELING AND FUNCTION AFTER MYOCARDIAL-INFARCTION

被引:45
|
作者
BONADUCE, D
PETRETTA, M
VILLARI, B
BREGLIO, R
CONFORTI, G
MONTEMURRO, MV
LANZILLO, T
MORGANO, G
机构
[1] Institute of Internal Medicine, Cardiology and Heart Surgery, Second School of Medicine, Naples
关键词
D O I
10.1016/0735-1097(90)90301-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the effects of late thrombolysis on left ventricular volume and function in acute myocardial infarction, two-dimensional echocardiography and radionuclide angiography were performed before discharge and after 1 year of follow-up study in 34 patients with acute anterior myocardial infarction. Of these, 10 admitted to the coronary care unit within 4 h from the onset of symptoms were treated with recombinant tissue-type plasminogen activator (rt-PA) (Group A) and 24 admitted between 4 and 8 h after onset were randomly assigned to receive either rt-PA (Group B, n = 12) or conventional therapy (Group C, n = 12). Seven to 10 days after admission, all patients underwent cardiac catheterization and coronary angiography. Patency of the infarct-related vessel was 70% in Group A, 66% in Group B and 33% in Group C and the average Thrombolysis in Myocardial Infarction (TIMI) coronary perfusion grade was 1.9 +/- 0.8 for Group A, 1.6 +/- 1.0 for Group B and 0.84 +/- 0.95 for Group C (Group A versus Group C p < 0.01; Group B versus Group C p < 0.05). At predischarge evaluation, mean left ventricular end-systolic and end-diastolic volumes were higher in Group C than in Group B (p < 0.001 and 0.05, respectively) and Group A (p < 0.005 for both); mean left ventricular ejection fraction at rest was lower in Group C than in Group B and Group A (p < 0.05 for both). At 1 year follow-up study, end-systolic and end-diastolic volumes remained higher in Group C than in Group B (p < 0.05 for both) and Group A (p < 0.005 for end-systolic volume and p < 0.001 for end-diastolic volume); ejection fraction at rest was lower in Group C than in Groups A and B (p < 0.05 for both); during exercise, it increased more in Group A than in Group C (p < 0.01). Comparison of data obtained before discharge and at the 1 year follow-up study revealed a significant difference in end-systolic volume (p < 0.05) in Group C patients and in end-diastolic volume in patients in Groups B (p < 0.05) and C (p < 0.001). The beneficial effect of late thrombolysis with rt-PA may be related to a reduction in myocardial expansion and thus to a favorable influence on postinfarction left ventricular remodeling.
引用
收藏
页码:1561 / 1568
页数:8
相关论文
共 50 条
  • [1] STREPTOKINASE OR TISSUE PLASMINOGEN-ACTIVATOR AND LEFT-VENTRICULAR FUNCTION AFTER MYOCARDIAL-INFARCTION
    WILLNER, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (10): : 688 - 688
  • [2] USEFULNESS OF LATE CORONARY THROMBOLYSIS (RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR) IN PRESERVING LEFT-VENTRICULAR FUNCTION IN ACUTE MYOCARDIAL-INFARCTION
    VILLARI, B
    PISCIONE, F
    BONADUCE, D
    GOLINO, P
    LANZILLO, T
    CONDORELLI, M
    CHIARIELLO, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (19): : 1281 - 1286
  • [3] IMPROVED LEFT-VENTRICULAR FUNCTION FOLLOWING INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    JOHNS, JA
    YASUDA, T
    GARABEDIAN, HD
    AARONSON, RA
    LEINBACH, RC
    AKINS, CW
    GOLD, HK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A190 - A190
  • [4] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    CIMMINIELLO, C
    [J]. LANCET, 1993, 342 (8862): : 48 - 49
  • [5] COMPARISON OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE FOR PRESERVATION OF LEFT-VENTRICULAR FUNCTION AFTER MYOCARDIAL-INFARCTION
    WHITE, HD
    RIVERS, JT
    NORRIS, RM
    TAKAYAMA, M
    MASLOWSKI, A
    HART, H
    SHARPE, N
    ORMISTON, J
    [J]. BRITISH HEART JOURNAL, 1989, 61 (01): : 72 - 72
  • [6] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    RIDKER, PM
    VAUGHAN, DE
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    [J]. LANCET, 1993, 341 (8854): : 1165 - 1168
  • [7] EFFECTIVENESS OF MULTIPLE BOLUS ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    KHAN, MI
    HACKETT, DR
    ANDREOTTI, F
    DAVIES, GJ
    REGAN, T
    HAIDER, AW
    MCFADDEN, E
    HALSON, P
    MASERI, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16): : 1051 - 1056
  • [8] INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND SIZE OF INFARCT, LEFT-VENTRICULAR FUNCTION, AND SURVIVAL IN ACUTE MYOCARDIAL-INFARCTION
    VANDEWERF, F
    ARNOLD, AER
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6660): : 1374 - 1379
  • [9] TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    GLAZIER, JJ
    CROWLEY, J
    CREMIN, D
    COLL, T
    DALY, K
    [J]. IRISH MEDICAL JOURNAL, 1989, 82 (03) : 111 - 114
  • [10] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    [J]. CIRCULATION, 1990, 82 (05) : 1668 - 1674